Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Peptides & Oligos Logo (drop shadow)

PART OF NEXTGEN BIOMED 2026

24 - 25 March 2026 | QEII Centre, London, UK

+ WORKSHOP DAY ON 23 MARCH 2026

Programme Summary

Delve into cutting-edge innovations in peptides and oligonucleotides discovery, therapeutics development & optimisation with key opinion leaders addressing novel computational tools, analytical strategies and sustainable chemistry & manufacturing practices.

Hear Peter Franko, Portfolio Director, introduce the programme

Build Your Personalised Agenda

See what you can't miss.

A personalised event programme built around your company, goals and interests — in seconds. No login required.

Untitled-3
Exhibitly AI Report Previews

DAY TWO

Peptides & Oligonucleotides Keynote Address

Fernando Albericio, Professor, University of KwaZulu-Natal

Fernando Albericio is a Research Professor at the University of KwaZulu-Natal (South Africa) and Emeritus Professor of Organic Chemistry at the University of Barcelona (Spain) with 50 years of experience in peptide chemistry.
His major research interests cover practically all aspects of peptide synthetic methodology as well as the synthesis of peptides and small molecules with therapeutic activities (cancer and infectious diseases). Lastly, he was working on greening the solid-phase peptide synthesis processes. He has published more than 1000 scientific articles, filed more than 60 patents, and graduated more than 80 Ph.D. students.

2026 Highlights

Peptides

Spotlight what’s next in peptide therapeutics - cutting-edge chemistry, AI/ML-driven
analysis, peptide display and sequencing, with case studies spanning oncology,
regenerative medicine, and beyond.

Oligonucleotides

Stay ahead in oligonucleotide discovery & optimisation - hear from GSK, Sixfold Bio,
Roche, Novo Nordisk and others on computational tools, novel mechanisms, delivery
breakthroughs, and clinical progress. 

NextGen Biomed - What to Expect Exhibiting 3
NextGen Biomed - What to Expect Networking 1
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments
NGB + LSX Combined Logo-1

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things NextGen Biomed, direct to your inbox.

NGB Newsletter Icon-1

Peptides & Oligonucleotides Agenda at a Glance

DAY ONE - 24 MARCH

Track 6: Peptide Discovery & Green Chemistry
Track 7: Oligonucleotide Discovery & Green Chemistry   

DAY TWO - 25 MARCH


Track 5: Peptide Therapeutics & Development 
Track 6: Oligonucleotide Therapeutic Development & Optimisation    

NextGen Biomed Conference Brochure

Meet Our Expert Speakers

Peptides again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Andrew Feilden
Senior Director Analytical Science,
Bicycle Therapeutics
Daniel Fleischanderl
Director Upstream Development,
Boehringer Ingelheim
Fernando Albericio
Research Professor,
University of KwaZulu-Natal
Hannah Bolt
Head of Peptide Discovery, Director,
AstraZeneca
Show More Speakers
Hide Speakers
Cécile Brocard
Head of Downstream Development,
Boehringer Ingelheim
Charles Johannes
Co-Founder & President,
FogPharma
David Rodríguez
Associate Director,
Novo Nordisk
Elisabetta Bianchi
Director,
Curium Biopharma
Fabien Rousset
Director Global Innovation,
PolyPeptide Group
Felix Wojcik
Principal Scientist,
Novo Nordisk
Kai Hilpert
Professor,
City St George's, University of London
Lukas Leder
Senior Principal Scientist,
Novartis
Mark Eccleston
Chief Executive Officer,
ValiRx
Michelle Barnard
Director of Research,
ValiRx
Mikhail Kuravskiy
Principal Scientist,
UCB
Sepideh Afshar
Senior Director,
Genentech
Sergio Martinez Cuesta
Principal Data Scientist,
AstraZeneca
Simin Chen
Peptide Researcher,
Asymchem Laboratories Inc

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Register Now

Be part of the new wave of Biomed R&D innovation

Partner with us

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients